Spiral Therapeutics Inc
Last verified 2026-05-08. JSON
| Total raised | $27.0M |
|---|---|
| Latest round | Funding round, $27.0M, 2025-09-30 |
| Founded | unknown |
| Headquarters | SOUTH SAN FRANCISCO, CA |
| Industry | pharmaceuticals |
| Stage | unknown |
| Website | spiraltherapeutics.com |
Spiral Therapeutics is a clinical-stage biotech developing therapies for inner ear disorders like hearing loss and balance conditions. It serves patients with conditions such as Meniere's disease and the clinicians treating them. Its MICS minimally-invasive cochlear platform delivers drugs directly to the cochlea while limiting systemic exposure.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-30 | Funding round | $27.0M | undisclosed |
Detected tech stack
PHP 7.4.33, WordPress 7.0, Twenty Twenty-One, WordPress Block Editor, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $27.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $27.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | spiraltherapeutics.com, read 2026-05-08 |
| Description | self-reported | spiraltherapeutics.com, read 2026-05-08 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $27.0M, 2025-09-30 → Funding round, $27.0M, 2025-09-30, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $27.0M, 2025-09-30 → Funding round, $27.0M, 2025-09-30 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes